Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen

Hassan Sibai, Fotios V. Michelis, MDPhD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Jieun Uhm, MD, Vikas Gupta, MD MRCP, MRCPath, John G. Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Hans A. Messner, PhD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Dennis Dong Hwan Kim, MDPhD

Blood (2014) 124 (21): 3870.

https://doi.org/10.1182/blood.V124.21.3870.3870

Published: 2014

Journal Articles

HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival

Marc Poch Martell, MD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Fotios V. Michelis, MDPhD, Jieun Uhm, MD, Feras Alfraih, MD, Mohamed Shanavas, MD FRACP, FRCPA, Vikas Gupta, MD FRCP, FRCPath, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD, Matthew D. Seftel, MRCP, FRCPC, MPH, Dennis Kim, MDPhD

Blood (2014) 124 (21): 3915.

https://doi.org/10.1182/blood.V124.21.3915.3915

Published: 2014

Journal Articles

The NIH Chronic Gvhd Global Score and the CIBMTR Risk Score Correlate Well with Failure Free Survival Following Frontline Systemic Corticosteroid Therapy for Chronic Gvhd

Jieun Uhm, MD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Elizabeth M Shin, Vikas Gupta, MD FRCP, FRCPath, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD, Matthew Seftel, MRCP, FRCPC, MPH, Dennis Dong Hwan Kim, MD PhD

Blood (2014) 124 (21): 3925.

https://doi.org/10.1182/blood.V124.21.3925.3925

Published: 2014

Journal Articles

The Risk Factors for IgG Hypogammaglobulinemia after Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Transplant Outcomes

Jieun Uhm, MD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Vikas Gupta, MD FRCP, FRCPath, John Kuruvilla, MD, Hans A. Messner, MD PhD, Matthew Seftel, MRCP, FRCPC, MPH, Jeffrey H. Lipton, MD PhD, Dennis D. Kim, MD PhD

Blood (2014) 124 (21): 3928.

https://doi.org/10.1182/blood.V124.21.3928.3928

Published: 2014

Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation In Aplastic Anemia Using Intermediate Dose Alemtuzumab Based-Conditioning

Nada Hamad, MBBS Hons, FRACP, FRCPA, Ryan Del Bel, B.Math, Hans A. Messner, M.D./Ph.D, Dennis Kim, MD, John Kuruvilla, MD, Jeffrey H. Lipton, MD, PhD, Jieun Uhm, MD, Wei Xu, Vikas Gupta, MD, FRCP, FRCPath

Blood (2013) 122 (21): 2044.

https://doi.org/10.1182/blood.V122.21.2044.2044

Published: 2013

Journal Articles

Risk Factors For Chronic Eye and Mouth GVHD In Unrelated Hematopoietic Cell Transplantation: T Cell Depletion Is The Only Risk Factor Identified and Appears To Be Favorable

Mohamed Shanavas, MD, FRACP, FRCPA, Nada Hamad, MBBS Hons, FRACP, FRCPA, Fotios V. Michelis, MD, PhD, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, FRCPC, Hans A. Messner, MD, PhD, Jeffrey H. Lipton, MD, PhD, Dennis Dong Hwan Kim, MD, PhD

Blood (2013) 122 (21): 4601.

https://doi.org/10.1182/blood.V122.21.4601.4601

Published: 2013

Journal Articles

The Risk Of BK Virus Haemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation Is Increased With Myeloablative Conditioning, CMV Viremia and Acute Gvhd

Jieun Uhm, MD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Mohamed Shanavas, MD, FRACP, FRCPA, Fotios V. Michelis, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, FRCPC, Hans A. Messner, MD, PhD, Jeffrey H. Lipton, MD, PhD, Dennis Kim, MD

Blood (2013) 122 (21): 3289.

https://doi.org/10.1182/blood.V122.21.3289.3289

Published: 2013

Journal Articles

Incidence, Risk Factors and Allogeneic Stem Cell Transplant Outcomes In Chronic Sclerotic Gvhd: T-Cell Depletion Is Preventive and Peripheral Blood Stem Cellis a Risk Factor, But Not HLA-Mismatch With No Adverse Impact On Transplant Outcomes

Jieun Uhm, MD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Mohamed Shanavas, MD, FRACP, FRCPA, Fotios V. Michelis, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, Hans A. Messner, MD, PhD, Jeffrey H. Lipton, MD, PhD, Dennis Dong Hwan Kim, MD, PhD

Blood (2013) 122 (21): 3293.

https://doi.org/10.1182/blood.V122.21.3293.3293

Published: 2013

Journal Articles

Mycophenolate Compared to Methotrexate As Part of Cyclosporine Based-GVHD Prophylaxis Does Not Affect Transplant Outcomes, Reduces Organ Specific Acute And Chronic GVHD, but Increases The Risk of CMV Viremia In Matched Related Donor Peripheral Blood Stem Cell Transplantation

Nada Hamad, MBBS Hons, FRACP, FRCPA, Mohamed Shanavas, MD, FRACP, FRCPA, Fotios V. Michelis, MD, PhD, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, M.D./Ph.D, Dennis Kim, MD

Blood (2013) 122 (21): 3303.

https://doi.org/10.1182/blood.V122.21.3303.3303

Published: 2013

NARROW

Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen

HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival

The NIH Chronic Gvhd Global Score and the CIBMTR Risk Score Correlate Well with Failure Free Survival Following Frontline Systemic Corticosteroid Therapy for Chronic Gvhd

The Risk Factors for IgG Hypogammaglobulinemia after Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Transplant Outcomes

Outcomes of Allogeneic Hematopoietic Cell Transplantation In Aplastic Anemia Using Intermediate Dose Alemtuzumab Based-Conditioning

Risk Factors For Chronic Eye and Mouth GVHD In Unrelated Hematopoietic Cell Transplantation: T Cell Depletion Is The Only Risk Factor Identified and Appears To Be Favorable

The Risk Of BK Virus Haemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation Is Increased With Myeloablative Conditioning, CMV Viremia and Acute Gvhd

Incidence, Risk Factors and Allogeneic Stem Cell Transplant Outcomes In Chronic Sclerotic Gvhd: T-Cell Depletion Is Preventive and Peripheral Blood Stem Cellis a Risk Factor, But Not HLA-Mismatch With No Adverse Impact On Transplant Outcomes

Mycophenolate Compared to Methotrexate As Part of Cyclosporine Based-GVHD Prophylaxis Does Not Affect Transplant Outcomes, Reduces Organ Specific Acute And Chronic GVHD, but Increases The Risk of CMV Viremia In Matched Related Donor Peripheral Blood Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only